MedDay has announced positive results from the pivotal Phase III clinical trial, MS-SPI demonstrating the efficacy and safety of MD...
Allergan plc and Gedeon Richter Plc ., announced positive topline results for RGH-MD-53, a Phase III study of cariprazine for...
MedDay reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD 1003 (biotin) in patients with...
MedDay has announced full study results from the MS-SPI and MS-ON trials, including the MS-SPI extension data on MD 1003...
Jazz Pharmaceuticals plc and The University of Texas MD Anderson Cancer Center announced a five-year strategic research collaboration agreement to evaluate zanidatamab, Jazz's investigational HER2-targeted bispecific antibody, in multiple HER2-expressing cancers
Therapeutics MD, Inc. announced that the FDA has approved Bijuva (estradiol and progesterone) capsules, 1 mg/100 mg, the first and...
FUJIFILM VisualSonics Inc., a world leader in ultra high frequency ultrasound imaging systems and subsidiary of FUJIFILM SonoSite, Inc., announced...
Allergan plc , announced positive results from ACHIEVE I (UBR-MD-01), the first of two pivotal phase III clinical trials evaluating...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion...